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The principal patbophysiotwgy of sick sinus yndrome is sinw 
node dysfooction cbxacterized bybradyarrhythmias (sinus 
bmdywdia. shmatrial ISA] block and sinus arrest) with or 
witbout wociated tachyanbythmias. In certain susceptible 
patients, tmosient marked sinus biadycardia or sinus paoser 
can result insymptomsofdiuioess or yncopeaod may lead to 
loo&term phamwdogic or pacemaker therapy. Altbougb the 
clinical course of sick sinus syodmme has oat been wetl 
investigaxd, implaotadoo f a pacemaker is not a0 ideal 
tbeiapy, became the syMbome has a relatively blnign progil* 
sis (1,2) and varies among patients. For these reasons. an 
appropriate pharmacologic therapy would be useful. However. 
diqwate resells have been reported re@rdiw previous phar- 
mwo4ogic tbempy for sick sinus yedmme, including vagolytic 
and betaadreoergic blocl;inp agents (3,4). 
Altboogb the cbmnic form of the syndrome is usually 
a&bed to degenerative-sclemtic changes in the sinus node 
and SA junctiw (5). patients with sinus node dysfunction are 
considered to be a rather hetemgeoeoos group. In 1985, Watt 
(6.7) proposed chat sick sinus syndrome is an adeoosine- 
twdiated isease: adenosioe is a mediator f the paroxysmal 
bradycaniia chamctelizing thesyodnne, and &eased semi- 
tivitv to adenosioe co&d account fw the a-&*&. 00 the 
basis of this hypothesis, several iovestigators t&ted the effects 
on sick sinus yndrome oftheopbylliw a methylated xaotbine 
thatisapotent~~ntagonistofadenosineRsite~eeptors.butthe 
rdts are contmvusial. Two years before the reports of Watt 
(6.71 and Be&i et al. (8) observed that b~haveooos i t%sioo f 
theophylline shatemd &ao sinus cycle length and decreased 
both estimated SA coodoctbx~ time ami maximal corrected 
sinus node recovery tine. Albooi et al. (9) repmted good 
effects of long-ten0 oral tbapbylline admbdstratiw 00 sious 
node disorders in 17 petieots with symptomatic sinus brady- 
cardii. However, little informatti s available about the ef- 
fects oftheophyllineon siiuspauses. Altwdet al. :9) observed 
that long-term oral admbdstmtioo of thqhyllire caused a
complete disappeawce of sinus paws that bed been MI’ d 
during Hdter ambulatory elsV (ECG) man - 
iog in four patients with sinus bndycadia. However. conflict- 
ing results have beeo rrported. Laid al. (10) sod Di&tozt(ll) 
failed to demonstrate  sigoilicaot effect of tbwphylline 00 
sinus node fun&n. I0 the present study we attempted to 
determine the effects of theophylline onsioos panes mani- 
fesied on 24-h Halter monitoring. 
Methods 
SabjceLc. We selected I7patients with type 2 sick sinus 
syndrome (classilication f Rubenstein [121: sinus arrest or 
SA block with a oause ~-2.5 s, not induced by drugs). 
Patients with paroxysmal atrial fibrillation, flutter or 
tachycardia (Rubenstein type 3) and sustained atrial tachy- 
cardia were not included in this study. Patients with sinus 
bradvcardia without sinus arrest or SA block !Rubenstein 
type I) were excluded from this study, as were patients with 
premature ventricular contractions greater than grade 3 
(Lawn classification il31) during Halter recordings. The 
criteria for exclusion included recent myocardial infarction: 
rrcote disease of any type: significant renal, hepatic, lung or 
cerebrovascular disease, and congestive heart failure. 
of the I7 patients, 8 were men and 9 were women. The 
average age was 59 rr I5 years (range 39 to 781. Two patients 
had hypertensive heart disease, 1 patient had ischemic heart 
disease and the remaining I4 had no signs of structural heart 
disease. All patients were in New York Heart Association 
functional class I or II. Ten patients reporter’ dizziness, two 
experienced fainting attacks and the other five reported 
asthenia or easy f&ability before hospitalization, but none 
had syncope. Five men were smokers at the time of entry 
into this study. Cardiovascular medications known IO sigif- 
icently interfere with the autonomic nervous system. ade- 
nosine metabolism and sinus node function were discontin- 
ued a4 weeks before the control Holler recordings were 
obtained and the patients were maintained without these 
drugs during the study. No patients were given digitalis. The 
following drugs were allowed: angiotensin-convetting en- 
zyme inhibitors for two hypertensive patients and long- 
acting nitrates and nicorandil (an antianginal agent acting as 
a potassium ion coronary vasodilator) for one patient with 
angina poctoris. 
Study protocel. Patients were followed up in the outpa- 
tient clinic throughout the study. A complete medical history 
was taken and physical examination was performed includ- 
ina chest X-ray study, echocardioaram, standard 12.lead 
E?G and standnrd laboratory tests for hematologic, thyroid, 
renal and hepatic function. Serum electrolyte, lipid and uric 
acid levels were also measured. Electrophysiologic studies 
were performed in five patients. Twenty-four-hour Halter 
monitoring was performed with a two-channel recorder. 
When more than two episodes of sinus arrest or SA block 
with a pause >2.5 s were Present in the record, Halter 
monitoring was repeated within 2 weeks. If more than two 
pauses were observed in the second record, the patient was 
included in the study. Data were analyzed to obtain mean 
24-h heart rate, minimal 24-h heart rate, tuoau heart rate 
every hour, longest RR interval and number of sinus pauses 
X.5 s. The number of ventricular uremalure heats was 
counted and the arrhythmia was classified according to 
Lown grade (13). The average data of the two records were 
used for this study. 
Oral theophylline treatment was then initiated at a dosage 
of 400 mg/dey in two divided doses using slow-release 
tablets. The drug was administered at approximately 8 .W 
and at 1 PM. After I week the effects of theophylline on 
Table 1. Effects of I Month of Oral Theophylline Treatment 
on Ambulatory ECG Variables in 17 Patients With Sick 
Sinus Svndrome 
corded. If a patient complained of palpitation, increased 
irritability. headache or dyspeptic symptoms. the dosage 
of theophylline was decreosed~to 200 mglday. One month 
after the initiation of theodvlline treatment, 24-h Halter 
monitoring was conducted.~S&um theophylline concentra- 
tion was determined on the same day as the second 24-h 
Halter recording, 3 to 4 h after the morning dose was taken. 
A clinical history, physical and mutine laboratory exam- 
inations and an ECG wore obtained at every visit. Of 
the I7 patients, I I were subsequently enrolled in a long-term 
study and were seen every 2 to 4 months. For personal 
reasons, three patients could not be followed up at our 
laboratory and were referred to a local physician: three other 
patients were not given long-term theophylline therapy be- 
cause of adverse effects (palpitation in one and mild nausea 
in two). Twenty-four-hour Holler monitoring and serum 
theophylliw level were obtained every 6 months during the 
follow-up period. 
The data were expressed es mean value = SD. The 
Wilcoxon teTt for paired data was used to evaluate the 
effects of theophyl’ine. Results were considered significant 
when the p value was C 0.05. 
ReSUltI 
ElTwto after 1 momh (Table 1, Ffg. I to 4). Fifteen of the 
I7 patients had been previously treated with vagolytlc agents 
(atrapine sulfate or scopolia extract) and beta-agonists (iso- 
preneline hydrochloride or orciprenaline sulfate) with disnp- 
Pointing results. The other :wo patients had not received 
pharmacologic therapy for sinus pauses. 
Systemic blood pressure averaged 136 + IO mm Hg 
before theophylline therapy and remained unchanged at 
I34 + II mm Hg during treatment. During theophylline 
therapy, mean 24-h heG rate increased in IS pat& by 
=tO beatslmin (from 51 2 9 to 61 -+ 10. D < 0.00. It did net . 
change significantly in the remaining two oetients, who had 
a rehdively hi heart r&e before therapy (Fig. I). The 
minims1 24-h heart rate increased by 32% (p < 0.01) during 
theophylline therapy in I5 patients; in 2 palients. Ihe differ- 
ence between minimal hc .rt rate before and during treatment 
subjective symptoms were evaluated and ECGs were re- was <S% (Fig. 2). Theophylline seemed to increase heart 
F@we 1. Effect of I month of theophylline therapy on mean Z4.h 
heart rate. Mean 24-h heart rate was increased stgnificanlly nt the 
end of 1 numb. 
rate slightly more in the d&me than during sleep (Fig. 3). 
The maximal duration of sinus pauses, which varied widely 
among patients (range 2.6 to 9.4 s for the Ion&S RR 
interval), decreased in all 17 patients by a mean of 51 + 21% 
from the control value: the duration of pauses decreased to 
46% of the control v&e in IO patie&. to 50% to 75% of 
the control value in 3 and to 76% tow% of the control value 
in 4 (Fig. 4). The daily number of pauses decreased fmm 
256 t 230 before theophyllia-e therapy to 23 + 62 during 
therapy: they disappeared completely in nine patients, de- 
creased to <IO% of the control value in six aad decreased 
fmm 329 to 108 in one natient and from 256 to 249 in one. 
The daily number of ve’ntricuiar pwttatur-e beats increased 
during theophylliae therapy from 86 ? 142:~ 122 = 209 beats 
(p = NS). All premature beats were monomorphic and did 
not last longer than two beats during three record&s. 
Subjective symptoms associated with sick sinus syndmme 
disappeared completely in 16 of 17 patients who experienced 
dizziness. faintaess, asthenia aad easy fatjgabjjty. IO one 
patient. mild diiness continued with no sigaficanl effects 
oa Holter KG records. 
Fit 4. EtTecc of L month of beophylline therapy on maximal RR 
interval. The maxinal RR interval wasdeeRasedioaU17patieat~at 
the end of I month. 
Fipre ‘2. E&c: d I month of l eophytline therapy on the minimal 
Mh heart rate. The minimal heart rate was increased significantly at
the end of I month. 
The serum theophylline level ranged from 3.0 to 
12.3 &ml (mean 8.6 2 2.8). There was no apparent corm 
lation between serum tbeophylline concentration and the 
percent change in any variable obtained with 24-h Halter 
monitoring: mean 24-h heart rate, minimal 24-h heart rate, 
maximal RR interval, number ofcardiac pauses and number 
of ventricular premature beats. Episodes of palpitation in 
one patient and nausea in two patients during initial tbeo- 
phylline therapy prevented these patients from entering the 
iong-term t&a&t phase. 
Imptern cllects (Tabk Z), Eleven patients (seven men 
and four women, mean age 57 + I6 years) received long 
term theophylline therapy. The follow-up p-a&d ranged 
from 8 to 37 months (mean 18.3 + 11.5). The initial dosage of 
theophylline as long-term therapy was 4M mg/day in nine 
patients and 200 mglday in two. Mean 24-h heart rate, 
minimal 24-h heart rate, maximal RR interval and number of 
sinus pauses during the control evaluation and at the end of 
I month of treatment were similar to those of the total group 
Of I7 uatients. In two patients (Patients 3 and 6). sinus 
pauses~disappcarcd com$etely (from 167 and 165 pauses, 
respectively) during the initia! 2 months of long-term therapy 
but gradually returned to control values alter 4 and 6 
months, respectively, despite significant serum theophylline 
levels (14.5 and 16.8 &III, respectively). In Patient 3, the 
maximal RR interval decreased from 4.6 to I.4 s during the 
initial 2 months of therapy but retunwl to 5.8 s 4 months 
later. In Patient 6. it was decreased from 9.4 to I.6 s at the 
end of the l-month study and increased to 6.6 s after a 
further 6 months. These two patients preferred pacemaker 
implantation over further medical treatment because of 
several spells of diuiness. In the remaining nine patients, 
favorable results were maintained for the number and dura- . 
. . 
&viIy and of Ca” transport (19). However, previws 
studies (20,21) suggest that ihe primary action of theop41yL 
line at therapwtic concentrations is the blockade of extra- 
ceUtdar R site Ai adeoosioe receptors. The negative cb 
notropic and dmmotropic effects of adenosine have already 
been described for both animal (22) and human heat% (23). - . IlOn ot smus pauses. tack of symptoms related to cardiac 
rhythm and adverse effects of theophylline (Table 2). ~tneopnyttme wmptetety antagonues the aegawe ciuono- 
mscussion 
Lhniitions of the study. In the present work we studied 
the effects of theophylline on siw pauses and heart rate 
changes doe to sinus oode dysfunction. We did not assess 
the effects of this drug in patients with bradycardia- 
tachycardia syndrome because an arrhythmogenic action of 
tbeophyllinc has been reported (14.15). Wtisnts with brady- 
cardia in the absence of cardiac pw~ses also were not studied 
because the wide day to day Ructeations in their heart rate 
would complicate interpretation of the data. 
Temporary and reversible maoifestalioos of sick sinus 
syndrome may be induced by vagotonia. Halter ambulatory 
ECG monitorina has clwlv demonstrated the in&ace of 
vagal tone on th; production of sinus pauses >2.0 S, even in 
normal subjects (IQ. However. we dkl not detail the contri- 
bution of vagal tone to sinus node dysfunction because in 
this study we did not conduct specitic analyses on the effects 
of vagolytic agents. 
mSsibk~ot~WneeucctwainaYpwc3. 
Tbeophylline exerts positive cbronetmpic and dmmetropic 
elects on the SA node and atrioventticular node cells. 
Mechanisms attributed to these effects of theophylline in- 
clude I) antagonism of the negative chmnotropic and dram 
lmpic effects of adenosine by competitive blocking of extra- 
cellular adenusine receptors (17), 2) release of e&genoos 
catecholamioes from sympathetic nerve endings and a&en- 
craic medulla (18). and 3) inhibition of ehosLcdierterase 
tropic and dmmotmpic action of adenosine-mediated extra- 
cellular Al receptors (17.19). Alternative mechanisms of 
theophylline action have been postulated in light of releasing 
etTccts norepinephrine fmm the adrenergic nerve terminals 
(24L inhibition of phosphodiesterase activity or of Ca” 
transport. Hawver. several observations (25-27) suggest 
that these actions of the drug appear at serum concentra- 
tions greater than the therapeutic range (W5 to IO-’ moV 
liter [Zglj. The plasma concentration of theophylline 
achieved in this study averaged 8.6 + 2.8 &ml (47 + 
15.4 ~moliliter). which is not high enough to increase the 
release of caiechoiamine and to inhibit phosphodiesterase 
activity. Thus, the increase in ca~echolamine r lease and the 
inhibition of phosphodiestrrdse actiGty were probably not 
responsible for the effects of fheophylline observed in the 
present study. 
Rote of sdenostne receptors in tong-term theophyttine 
effects. In 2 of II patients who received long-term treat- 
ment, theophylline failed to maintain its effect on sinus 
~;.w+es for >6 months despite a significant inirial e&t, 
which led these patients to choose pxemzker implantation. 
The plasma concentrations 21’ theophylline in these two 
patients at the ettd of the last Halter monitoring period were 
not simthicantlv d&rent from the levels nt the end of the 
I-month studyi7.5 and 9.6 mglml). 
Recently it was shown (29) that cardiac adenosine A, 
receptors can be tqxegulated by long-term treatment with 
theophylline. Thic up-regulation is accompanied by en- 
h&d sensitivity of ventriinlar myocytes LO :he Electra 
physiologic actions of adenosine. including negative 
chmnotropic and dromotmpic actions. If this is the case in 
human SA node cells, long_tetm treatment with theophylline 
would increase the adenosine sensitivity of the cells, which 
would lead to gradual attenuation of the A, receptor- 
blocking effect of theophylline and to a reappearance of 
adenosi&nduced SA node dysfunction. This &-egulation 
of adenosine receptors and enhanced sensitivity of the SA 
node cells to adenosine may have been involved in the 
desensitization to theophylline observed after long-term 
treatment in the two patients who chose pacemaker implan- 
tation. 
Dosage and dverae offsets of tbwpbylline. Despite the 
apparent beneficial effects of theophylline in many of our 
patients, three patients could not tolerate long-term therapy. 
Nausea resulted in the termination of long-Mm drug therapy 
in two patients, and palpitation resulted in the discontinua- 
iion of Ihe agent in one patient at the end of the l-month 
study. In general, however. theophylline Therapy was not 
asswia~ed with serious adverse ttfects or !oxicity in our 
patients. The present data suggest thai :heophylline treat- 
ment should be initiated at a dosage of 200 to 400 mg/day. 
which can then be slightly changed according to the clinical 
mttr:z of the patient. 
Need for fwthw study. Since the frequency and sevetity 
of transient bradyarrhythmias may vary from day to day and 
from patient to patient, a controlled long-term study i; 
required to mret’pret he etlicacy of thcophylline therapy. 
Conch&or. This study examined the effefts of oral 
admimstration of theophyllin? on cardiac pauses in I7 
patients with sick sinus syndrome. Theophylline, 200 to 
400 mgiday. decreased frequency of sinus pauses per 
24 h and decreased dxatioo of the lonaest ~~ause.s after 
I month of treatment. Adverse effects &e bbserved in 
thse patients. A goad outcome was maintained in 9 of II 
patients recewmg long-temt treatment. Two patients expe- 
rienced recurrence of long sinus pauxs and symptoos and 
required a pacsnwer. Thus. the results suS&zI that Einus 
pauses in sick sinus syndrome may be treated favorably with 
oral thcophylline. 
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